Valuation: Skystar Bio-Pharmaceutical Company

Market Cap 36.7M 32.23M 29.98M 27.51M 51.69M 3.53B 52.48M 356M 139M 1.74B 138M 135M 6.01B P/E 2012
1.93x
P/E 2013 2.56x
Enterprise Value 39.2M 34.43M 32.02M 29.38M 55.2M 3.77B 56.06M 380M 149M 1.86B 147M 144M 6.42B EV / Sales 2012
0.2x
EV / Sales 2013 0.69x
Free-Float
100%
Yield 2012 *
-
Yield 2013 -
15-12-20 Skystar Bio Pharmaceutical Company(NasdaqCM:SKBI) dropped from NASDAQ Composite Index CI
14-11-14 Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal 2014 CI
14-11-14 Skystar Bio Mulls Acquisitions CI
14-08-26 Skystar to Launch Probiotic Supplement for Dairy Cows by End of Fiscal 2014 CI
14-08-14 Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Revenue Guidance for the 2014 CI
14-07-16 Skystar Bio Pharmaceutical Mulls Acquisitions CI
14-07-08 Skystar Launches Bovine Immunoglobulin G Kits in China CI
14-05-15 Skystar Bio Pharmaceutical Company Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Reaffirms Revenue Guidance for the Year 2014 CI
14-03-31 Skystar Bio-Pharmaceutical Company Announces Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Revenue Guidance for the Year 2014 CI
13-12-04 Skystar Bio Mulls Acquisitions CI
13-11-15 Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Reiterates Earnings Guidance for the Fiscal 2013 CI
13-08-14 Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2013; Reiterates Earnings Guidance of 2013 CI
13-05-15 Skystar Bio Pharmaceutical Company Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2013; Reiterates Revenue Guidance for the Year 2013 CI
Director TitleAgeSince
Director/Board Member 60 2008-06-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+408.41%+629.49% 40.23B
-0.27%+4.45%+9.93%+66.92% 36.23B
+0.35%+0.87%+3.60%-8.81% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+31.97%+143.53% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%+0.76%+8.50% 13.12B
-2.68%-2.49%-15.00%-31.68% 12.7B
Average +0.20%+0.75%+54.97%+107.37% 24.53B
Weighted average by Cap. +0.48%+0.91%+75.32%+136.64%

Financials

2012 2013
Net sales 33.59M 29.5M 27.43M 25.17M 47.3M 3.23B 48.03M 326M 127M 1.59B 126M 123M 5.5B 42.48M 37.31M 34.7M 31.84M 59.83M 4.09B 60.75M 412M 161M 2.01B 159M 156M 6.95B
Net income 6.21M 5.46M 5.07M 4.66M 8.75M 598M 8.88M 60.26M 23.54M 294M 23.32M 22.82M 1.02B 10.53M 9.25M 8.6M 7.89M 14.83M 1.01B 15.06M 102M 39.9M 499M 39.53M 38.68M 1.72B
Net Debt -5.61M -4.93M -4.58M -4.2M -7.9M -540M -8.02M -54.4M -21.25M -266M -21.05M -20.6M -918M 2.5M 2.19M 2.04M 1.87M 3.52M 241M 3.57M 24.23M 9.47M 118M 9.38M 9.18M 409M
Logo Skystar Bio-Pharmaceutical Company
Skystar Bio-Pharmaceutical Co., Ltd. is a manufacturer and distributor of veterinary medicines and healthcare products in China. The Company develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine (TCM); topicals, supplements, probiotics, and diagnostic kits and animal, animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets within China. The Company operates four product lines: Probiotics, Veterinary Medicine, Veterinary Vaccines and Feed Additives. The Company provides a range of veterinary products serving regional micro-farms offering, such as Veterinary vaccines, including aquaculture, Veterinary medicines, Pro-biotic microorganisms and Animal feed additives. The Company's Veterinary drug products include Ivermectin Premix, Feizhu San, Tilmicosin Premix, Stimulated egg powder, Wulingsan, Yimu Shenghua San, Qingwen Baidu San and Spectinomycin Hydrochloride Injection.
Employees
-
  1. Stock Market
  2. Stocks
  3. SKBI Stock